O Leary Sean T, Maldonado Yvonne A, Kimberlin David W
Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
Department of Pediatrics, Stanford University School of Medicine, Palo Alto, California, USA.
J Pediatric Infect Dis Soc. 2020 Dec 31;9(6):645-649. doi: 10.1093/jpids/piaa144.
The Advisory Committee on Immunization Practices (ACIP), a group of medical and public health experts, normally meets 3 times per year to develop recommendations for vaccine use in the United States. Because of the severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) pandemic, there are several SARS-CoV-2 vaccines currently in late-stage clinical trials, so the ACIP is now meeting monthly for single day meetings, with plans to continue standard 2- to 3-day meetings as per usual (February, June, and October). Emergency meetings of ACIP may occur if a vaccine candidate receives an Emergency Use Authorization from the food and drug administration (FDA). This Update provides a combined summary of the August 26 and September 22, 2020, meetings, both of which focused completely on Coronavirus disease 2019 (COVID-19) vaccines. The representatives from the American Academy of Pediatrics (Y. A. M. and D. W. K.) and the Pediatric Infectious Diseases Society (S. T. O.) are present as liaisons to the ACIP.
免疫实践咨询委员会(ACIP)由医学和公共卫生专家组成,通常每年召开3次会议,以制定美国疫苗使用建议。由于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)大流行,目前有几种SARS-CoV-2疫苗正处于后期临床试验阶段,因此ACIP现在每月举行为期一天的会议,并计划按惯例继续举行标准的为期2至3天的会议(2月、6月和10月)。如果候选疫苗获得食品药品监督管理局(FDA)的紧急使用授权,ACIP可能会召开紧急会议。本更新内容汇总了2020年8月26日和9月22日会议的情况,这两次会议均完全聚焦于2019冠状病毒病(COVID-19)疫苗。美国儿科学会(Y.A.M.和D.W.K.)以及儿科传染病学会(S.T.O.)的代表作为与ACIP的联络人出席了会议。